HEADER TRANSFERASE 17-NOV-09 3KQJ TITLE MURA BINARY COMPLEX WITH UDP-N-ACETYLGLUCOSAMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: UDP-N-ACETYLGLUCOSAMINE 1-CARBOXYVINYLTRANSFERASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ENOYLPYRUVATE TRANSFERASE, UDP-N-ACETYLGLUCOSAMINE COMPND 5 ENOLPYRUVYL TRANSFERASE, EPT; COMPND 6 EC: 2.5.1.7; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 83333; SOURCE 4 STRAIN: K12; SOURCE 5 GENE: B3189, JW3156, MURA, MURA (MURZ), MURZ; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET41A KEYWDS CLOSED ENZYME STATE, INSIDE-OUT ALPHA/BETA BARREL, CELL CYCLE, CELL KEYWDS 2 DIVISION, CELL SHAPE, CELL WALL BIOGENESIS/DEGRADATION, KEYWDS 3 PEPTIDOGLYCAN SYNTHESIS, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR E.SCHONBRUNN REVDAT 4 27-JUL-11 3KQJ 1 HETNAM HETSYN REVDAT 3 13-JUL-11 3KQJ 1 VERSN REVDAT 2 05-MAY-10 3KQJ 1 JRNL REVDAT 1 28-APR-10 3KQJ 0 JRNL AUTH H.HAN,Y.YANG,S.H.OLESEN,A.BECKER,S.BETZI,E.SCHONBRUNN JRNL TITL THE NATURAL PRODUCT ANTIBIOTIC TERREIC ACID IS A JRNL TITL 2 MECHANISM-BASED INHIBITOR OF THE BACTERIAL ENZYME MURA IN JRNL TITL 3 VITRO BUT NOT IN VIVO. JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.4 REMARK 3 NUMBER OF REFLECTIONS : 57712 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.168 REMARK 3 FREE R VALUE : 0.195 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1155 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.81 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2030 REMARK 3 BIN FREE R VALUE : 0.2250 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 178 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.017 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3142 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 50 REMARK 3 SOLVENT ATOMS : 470 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.16 REMARK 3 ESD FROM SIGMAA (A) : 0.06 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.19 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.07 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.50 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3KQJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-DEC-09. REMARK 100 THE RCSB ID CODE IS RCSB056321. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-JUL-09 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.542 REMARK 200 MONOCHROMATOR : MIRRORS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS HTC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 57712 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 200 DATA REDUNDANCY : 5.100 REMARK 200 R MERGE (I) : 0.06200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.1 REMARK 200 DATA REDUNDANCY IN SHELL : 4.20 REMARK 200 R MERGE FOR SHELL (I) : 0.19000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 6.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 1RYW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.89 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.92 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12.5 MM NA-FORMATE, 25 MM NA/K REMARK 280 PHOSPHATE, 10% PEG 3350, PH 7.0, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 30.28000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 67.49500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.06500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 67.49500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 30.28000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 32.06500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 116 47.65 -88.17 REMARK 500 SER A 349 -121.25 58.81 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 588 DISTANCE = 5.03 ANGSTROMS REMARK 525 HOH A 751 DISTANCE = 6.53 ANGSTROMS REMARK 525 HOH A 788 DISTANCE = 5.43 ANGSTROMS REMARK 525 HOH A 835 DISTANCE = 5.03 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 420 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UD1 A 450 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 421 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3KQA RELATED DB: PDB REMARK 900 MURA DEAD-END COMPLEX WITH TERREIC ACID REMARK 900 RELATED ID: 3KR6 RELATED DB: PDB REMARK 900 MURA DEAD-END COMPLEX WITH FOSFOMYCIN REMARK 999 REMARK 999 SEQUENCE REMARK 999 ASP67 FORMS AN ISOPEPTIDIC BOND AND IS A RESULT OF REMARK 999 POSTTRANSLATIONAL MODIFICATION OF ASN67 DBREF 3KQJ A 1 419 UNP P0A749 MURA_ECOLI 1 419 SEQADV 3KQJ IAS A 67 UNP P0A749 ASN 67 SEE REMARK 999 SEQRES 1 A 419 MET ASP LYS PHE ARG VAL GLN GLY PRO THR LYS LEU GLN SEQRES 2 A 419 GLY GLU VAL THR ILE SER GLY ALA LYS ASN ALA ALA LEU SEQRES 3 A 419 PRO ILE LEU PHE ALA ALA LEU LEU ALA GLU GLU PRO VAL SEQRES 4 A 419 GLU ILE GLN ASN VAL PRO LYS LEU LYS ASP VAL ASP THR SEQRES 5 A 419 SER MET LYS LEU LEU SER GLN LEU GLY ALA LYS VAL GLU SEQRES 6 A 419 ARG IAS GLY SER VAL HIS ILE ASP ALA ARG ASP VAL ASN SEQRES 7 A 419 VAL PHE CYS ALA PRO TYR ASP LEU VAL LYS THR MET ARG SEQRES 8 A 419 ALA SER ILE TRP ALA LEU GLY PRO LEU VAL ALA ARG PHE SEQRES 9 A 419 GLY GLN GLY GLN VAL SER LEU PRO GLY GLY CYS THR ILE SEQRES 10 A 419 GLY ALA ARG PRO VAL ASP LEU HIS ILE SER GLY LEU GLU SEQRES 11 A 419 GLN LEU GLY ALA THR ILE LYS LEU GLU GLU GLY TYR VAL SEQRES 12 A 419 LYS ALA SER VAL ASP GLY ARG LEU LYS GLY ALA HIS ILE SEQRES 13 A 419 VAL MET ASP LYS VAL SER VAL GLY ALA THR VAL THR ILE SEQRES 14 A 419 MET CYS ALA ALA THR LEU ALA GLU GLY THR THR ILE ILE SEQRES 15 A 419 GLU ASN ALA ALA ARG GLU PRO GLU ILE VAL ASP THR ALA SEQRES 16 A 419 ASN PHE LEU ILE THR LEU GLY ALA LYS ILE SER GLY GLN SEQRES 17 A 419 GLY THR ASP ARG ILE VAL ILE GLU GLY VAL GLU ARG LEU SEQRES 18 A 419 GLY GLY GLY VAL TYR ARG VAL LEU PRO ASP ARG ILE GLU SEQRES 19 A 419 THR GLY THR PHE LEU VAL ALA ALA ALA ILE SER ARG GLY SEQRES 20 A 419 LYS ILE ILE CYS ARG ASN ALA GLN PRO ASP THR LEU ASP SEQRES 21 A 419 ALA VAL LEU ALA LYS LEU ARG ASP ALA GLY ALA ASP ILE SEQRES 22 A 419 GLU VAL GLY GLU ASP TRP ILE SER LEU ASP MET HIS GLY SEQRES 23 A 419 LYS ARG PRO LYS ALA VAL ASN VAL ARG THR ALA PRO HIS SEQRES 24 A 419 PRO ALA PHE PRO THR ASP MET GLN ALA GLN PHE THR LEU SEQRES 25 A 419 LEU ASN LEU VAL ALA GLU GLY THR GLY PHE ILE THR GLU SEQRES 26 A 419 THR VAL PHE GLU ASN ARG PHE MET HIS VAL PRO GLU LEU SEQRES 27 A 419 SER ARG MET GLY ALA HIS ALA GLU ILE GLU SER ASN THR SEQRES 28 A 419 VAL ILE CYS HIS GLY VAL GLU LYS LEU SER GLY ALA GLN SEQRES 29 A 419 VAL MET ALA THR ASP LEU ARG ALA SER ALA SER LEU VAL SEQRES 30 A 419 LEU ALA GLY CYS ILE ALA GLU GLY THR THR VAL VAL ASP SEQRES 31 A 419 ARG ILE TYR HIS ILE ASP ARG GLY TYR GLU ARG ILE GLU SEQRES 32 A 419 ASP LYS LEU ARG ALA LEU GLY ALA ASN ILE GLU ARG VAL SEQRES 33 A 419 LYS GLY GLU HET IAS A 67 8 HET GOL A 420 6 HET UD1 A 450 39 HET PO4 A 421 5 HETNAM IAS BETA-L-ASPARTIC ACID HETNAM GOL GLYCEROL HETNAM UD1 URIDINE-DIPHOSPHATE-N-ACETYLGLUCOSAMINE HETNAM PO4 PHOSPHATE ION HETSYN IAS L-ASPARTIC ACID HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 IAS C4 H7 N O4 FORMUL 2 GOL C3 H8 O3 FORMUL 3 UD1 C17 H27 N3 O17 P2 FORMUL 4 PO4 O4 P 3- FORMUL 5 HOH *470(H2 O) HELIX 1 1 ALA A 21 ALA A 32 1 12 HELIX 2 2 LEU A 33 ALA A 35 5 3 HELIX 3 3 LEU A 47 LEU A 60 1 14 HELIX 4 4 PRO A 83 LYS A 88 1 6 HELIX 5 5 THR A 89 MET A 90 5 2 HELIX 6 6 ARG A 91 TRP A 95 5 5 HELIX 7 7 ALA A 96 GLY A 105 1 10 HELIX 8 8 VAL A 122 LEU A 132 1 11 HELIX 9 9 SER A 162 THR A 174 1 13 HELIX 10 10 GLU A 188 LEU A 201 1 14 HELIX 11 11 ASP A 231 ARG A 246 1 16 HELIX 12 12 GLN A 255 THR A 258 5 4 HELIX 13 13 LEU A 259 ALA A 269 1 11 HELIX 14 14 PRO A 303 ASP A 305 5 3 HELIX 15 15 MET A 306 ALA A 317 1 12 HELIX 16 16 MET A 333 ARG A 340 1 8 HELIX 17 17 ASP A 369 ALA A 383 1 15 HELIX 18 18 ILE A 392 GLY A 398 5 7 HELIX 19 19 ARG A 401 LEU A 409 1 9 SHEET 1 A 4 GLN A 364 MET A 366 0 SHEET 2 A 4 GLY A 385 ASP A 390 1 O VAL A 388 N VAL A 365 SHEET 3 A 4 LYS A 3 GLY A 8 -1 N VAL A 6 O THR A 387 SHEET 4 A 4 ASN A 412 VAL A 416 -1 O GLU A 414 N ARG A 5 SHEET 1 B 4 GLY A 14 THR A 17 0 SHEET 2 B 4 LYS A 248 ARG A 252 1 O ARG A 252 N VAL A 16 SHEET 3 B 4 TRP A 279 ASP A 283 -1 O ILE A 280 N CYS A 251 SHEET 4 B 4 ASP A 272 VAL A 275 -1 N GLU A 274 O SER A 281 SHEET 1 C 4 LYS A 63 ARG A 66 0 SHEET 2 C 4 VAL A 70 ASP A 73 -1 O HIS A 71 N GLU A 65 SHEET 3 C 4 VAL A 39 GLN A 42 -1 N ILE A 41 O VAL A 70 SHEET 4 C 4 GLY A 224 ARG A 227 1 O TYR A 226 N GLN A 42 SHEET 1 D 3 GLN A 106 SER A 110 0 SHEET 2 D 3 TYR A 142 SER A 146 -1 O VAL A 143 N VAL A 109 SHEET 3 D 3 THR A 135 GLU A 139 -1 N THR A 135 O SER A 146 SHEET 1 E 4 HIS A 155 VAL A 157 0 SHEET 2 E 4 THR A 179 GLU A 183 1 O GLU A 183 N ILE A 156 SHEET 3 E 4 ARG A 212 GLU A 216 -1 O ILE A 213 N ILE A 182 SHEET 4 E 4 LYS A 204 SER A 206 -1 N SER A 206 O VAL A 214 SHEET 1 F 4 VAL A 294 ARG A 295 0 SHEET 2 F 4 THR A 320 THR A 324 1 O THR A 324 N VAL A 294 SHEET 3 F 4 THR A 351 HIS A 355 -1 O CYS A 354 N GLY A 321 SHEET 4 F 4 HIS A 344 GLU A 348 -1 N GLU A 346 O ILE A 353 LINK CG IAS A 67 N GLY A 68 1555 1555 1.24 LINK C ARG A 66 N IAS A 67 1555 1555 1.45 CISPEP 1 GLY A 8 PRO A 9 0 0.24 CISPEP 2 HIS A 299 PRO A 300 0 0.75 SITE 1 AC1 6 HIS A 155 PHE A 322 THR A 351 HOH A 533 SITE 2 AC1 6 HOH A 673 HOH A 710 SITE 1 AC2 34 LYS A 22 ASN A 23 ARG A 91 TRP A 95 SITE 2 AC2 34 ARG A 120 PRO A 121 VAL A 122 ASP A 123 SITE 3 AC2 34 LEU A 124 HIS A 125 LYS A 160 SER A 162 SITE 4 AC2 34 VAL A 163 GLY A 164 THR A 304 ASP A 305 SITE 5 AC2 34 VAL A 327 PHE A 328 ARG A 331 PO4 A 421 SITE 6 AC2 34 HOH A 478 HOH A 482 HOH A 492 HOH A 496 SITE 7 AC2 34 HOH A 505 HOH A 508 HOH A 515 HOH A 535 SITE 8 AC2 34 HOH A 543 HOH A 578 HOH A 625 HOH A 736 SITE 9 AC2 34 HOH A 814 HOH A 858 SITE 1 AC3 9 LYS A 22 GLY A 114 CYS A 115 ARG A 120 SITE 2 AC3 9 ARG A 397 UD1 A 450 HOH A 471 HOH A 543 SITE 3 AC3 9 HOH A 814 CRYST1 60.560 64.130 134.990 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016513 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015593 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007408 0.00000 MASTER 269 0 4 19 23 0 14 6 0 0 0 33 END